Clinical trial
Efficacy of a Non-Invasive Endometrial Receptivity Prediction Model Based on Peripheral Blood miRNA Signatures During the Peri-Implantation Period in Improving IVF Outcomes in Patients With Unexplained Recurrent Implantation Failure: A Prospective, Single-Blind, Two-Arm, Parallel Randomized Controlled Trial
NCT07363018 is registered in ClinicalTrials.gov with Tang-Du Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of a Non-Invasive Endometrial Receptivity Prediction Model Based on Peripheral Blood miRNA Signatures During the Peri-Implantation Period in Improving IVF Outcomes in Patients With Unexplained Recurrent Implantation Failure: A Prospective, Single-Blind, Two-Arm, Parallel Randomized Controlled Trial
- Lead sponsor
- Tang-Du Hospital
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- February 28, 2026
- Completion date
- September 30, 2027
- Enrollment
- 546 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
recurrent implantation failure